Voloridge Investment Management
ADVM

Voloridge Investment Management’s Adverum Biotechnologies ADVM Stock Holding History

Voloridge Investment Management’s Portfolio ADVM Stock Details ADVM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-5,436
Closed -$560K – 1288
2020
Q3 		$560K Buy
5,436
+4,390
+420% +$657K ﹤0.01% 1072
2020
Q2 		$218K Sell
1,046
-1,926
-65% -$341K ﹤0.01% 1183
2020
Q1 		$290K Buy
+2,972
New +$347K 0.01% 879
2019
Q4 		– Sell
-11,596
Closed -$632K – 1053
2019
Q3 		$632K Buy
+11,596
New +$1.31M 0.01% 744

Other funds holding ADVM

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
SFI
Sonic Fund II Honolulu, Hawaii $147M AUM 19.98% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

Voloridge Investment Management's ADVM Position: Q4 2020 in Review

Voloridge Investment Management sold out of Adverum Biotechnologies (ADVM) in Q4 2020, closing a stake of 5,436 shares — an estimated $560K sold.

Voloridge Investment Management first reported a position in ADVM in Q3 2019 and held it in 4 quarters. The position peaked at $632K in Q3 2019. 155 funds tracked by Wall St. Rank hold ADVM as of Q4 2020.

  • Voloridge Investment Management reported no remaining Adverum Biotechnologies position as of Q4 2020 after selling out during the quarter.
  • Voloridge Investment Management sold 5,436 Adverum Biotechnologies shares in Q4 2020, an estimated $560K.
  • Voloridge Investment Management first reported a position in Adverum Biotechnologies in Q3 2019 and held it in 4 quarters.
  • Voloridge Investment Management's Adverum Biotechnologies position peaked at $632K in Q3 2019.
  • 155 funds tracked by Wall St. Rank held Adverum Biotechnologies as of Q4 2020.

Based on Voloridge Investment Management's 13F filing for Q4 2020, filed 16 Feb 2021.